Skip to main content
Fig. 1 | Diagnostic Pathology

Fig. 1

From: Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique

Fig. 1

The study workflow. All cases were tested by the KRAS LCD-array Kit and MALDI MS. If a mutation was found by the KRAS LCD-array Kit, a report was signed out. If no mutation was detected by the KRAS LCD-array Kit, that covers exclusively exon 2, Sanger sequencing has been performed for KRAS, NRAS and BRAF in exon 2–4 and a report was signed out accordingly

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us